To validate the role of tumor-intrinsic IFNγ signaling in antitumor immune responses uncovered in the screen, we generated Ifngr2−/− KPAR cell lines using CRISPR–Cas9 (Supplementary Fig. S2A). The gene discussed is IFNG; the disease is neoplasm.